Skin absorption modulation: Innovative non-hazardous technologies for topical formulations

Open Dermatology Journal

Volumn 4, Issue 1, 2010, Pages 3-9

  Atrux Tallau, Nicolas ^a   Denis, Alain ^b   Padois, Karine ^a,c   Bertholle, Valérie ^a   Huynh, Truc Thanh Ngoc ^a   Haftek, Marek ^a   Falson, Françoise ^a   Pirot, Fabrice ^a,d  

^a Clinical and Therapeutic Aspects of the Skin Barrier Function   (France)

^b Laboratoire dermatologique Bioderma   (France)

^c HOSPICES CIVILS DE LYON   (France)

^d Groupement Hospitalier Edouard Herrio   (France)

Author keywords

Nanostructured lipid carriers; Nanotherapeutic; Skin diseases; Solid lipid nanoparticles

Indexed keywords

4' AMINOMETHYL 4,5',8 TRIMETHYLPSORALEN; CHLORHEXIDINE; CLOBETASOL PROPIONATE; CLOTRIMAZOLE; DAUNORUBICIN; DICLOFENAC DIETHYLAMINE; DRUG CARRIER; DRUG SOLVENT; ENOXACIN; FLUOROURACIL; GONADORELIN; INDOMETACIN; ISOTRETINOIN; MINOXIDIL; NANOCARRIER; NIMESULIDE; NIOSOME; PODOPHYLLOTOXIN; PREDNICARBATE; PSORALEN; RETINOIC ACID; RETINOL; SOLID LIPID NANOPARTICLE; TRIPTOLIDE;

ARTICLE; DRUG CONCENTRATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG TRANSPORT; MEDICAL TECHNOLOGY; METABOLISM; MICROEMULSION; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SKIN ABSORPTION; SKIN PERMEABILITY; STRATUM CORNEUM;

EID: 77953741249     PISSN: None     EISSN: 18743722     Source Type: Journal    
DOI: 10.2174/1874372201004010003     Document Type: Article

References (64)

1. Atrux-Tallau N, Falson F, Pirot F. In: Lamprecht A, Ed. Nanotherapeutics for skin diseases. Singapore, Pan Stanford Publishing Pte. Ltd. 2009; 125-61.
2. Moghimi HR, Williams AC, Barry BW. A lamellar matrix model for stratum corneum intercellular lipids. II. Effect of geometry of the stratum corneum on permeation of model drugs 5-fluorouracil and oestradiol. Int J Pharm 1996; 131(2): 117-29.
3. Pirot F, Padois K, Haftek M, Falson F. Nanoparticules lipidiques solides encapsulant du minoxidil et suspension aqueuse les contenant. France patent FR 09 52059, 2009.
4. Date AA, Naik B, Nagarsenker MS. Novel drug delivery systems: Potential in improving topical delivery of antiacne agents. Skin Pharmacol Physiol 2006; 19(1): 2-16.
5. Jores K, Mehnert W, Drechsler M, et al. Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy. J Control Release 2004; 95(2): 217-27.
6. Schubert MA, Muller-Goymann CC. Solvent injection as a new approach for manufacturing lipid nanoparticles-evaluation of the method and process parameters. Eur J Pharms Biopharm 2003; 55(1): 125-31.
7. Muller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 2002; 54(Supplement 1): S131-S155.
8. Santos Maia C, Mehnert W, Schaller M, et al. Drug targeting by solid lipid nanoparticles for dermal use. J Drug Target 2002; 10(6): 489-95.
9. Liu J, Hu W, Chen H, et al. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. Int J Pharm 2007; 328(2): 191-5.
10. Jenning V, Gysler A, Schafer-Korting M, Gohla SH. Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. Euro J Pharm Biopharm 2000; 49(3): 211-8.
11. Chen H, Chang X, Du D, et al. Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting. J Control Release 2006; 110(2): 296-306.
12. Mei Z, Chen H, Weng T, Yang Y, Yang X. Solid lipid nanoparticle and microemulsion for topical delivery of triptolide. Eur J Pharm Biopharm 2003; 56(2): 189-96.
13. Maia CS, Mehnert W, Schafer-Korting M. Solid lipid nanoparticles as drug carriers for topical glucocorticoids. Int J Pharm 2000; 196(2): 165-7.
14. Fang JY, Fang CL, Liu CH, Su YH. Lipid nanoparticles as vehicles for topical psoralen delivery: Solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Eur J Pharm Biopharm 2008; 70(2): 633-40.
15. Souto EB, Wissing SA, Barbosa CM, Muller RH. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm 2004; 278(1): 71-7.
16. Saupe A, Gordon KC, Rades T. Structural investigations on nanoemulsions, solid lipid nanoparticles and nanostructured lipid carriers by cryo-field emission scanning electron microscopy and Raman spectroscopy. Int J Pharm 2006; 314(1): 56-62.
17. Hu F-Q, Jiang S-P, Du Y-Z, et al. Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloids Surf B Biointerfaces 2005; 45(3-4): 167-73.
18. Hu F-Q, Jiang S-P, Du Y-Z, et al. Preparation and characteristics of monostearin nanostructured lipid carriers. Int J Pharm 2006; 314(1): 83-9.
19. Castelli F, Puglia C, Sarpietro MG, Rizza L, Bonina F. Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry. Int J Pharm 2005; 304(1-2): 231-8.
20. Lombardi Borgia S, Regehly M, Sivaramakrishnan R, et al. Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy. J Control Release 2005; 110(1): 151-63.
21. Kang BK, Chon SK, Kim SH, et al. Controlled release of paclitaxel from microemulsion containing PLGA and evaluation of anti-tumor activity in vitro and in vivo. Int J Pharm 2004; 286(1-2): 147-56.
22. Danielsson I, Lindman B. The definition of microemulsion. Colloids Surf 1981; 3(4): 391-2.
23. Kreilgaard M. Influence of microemulsions on cutaneous drug delivery. Adv Drug Deliv Rev 2002; 54(Supplement 1): S77-S98.
24. Chen H, Chang X, Du D, et al. Microemulsion-based hydrogel formulation of ibuprofen for topical delivery. Int J Pharm 2006; 315(1-2): 52-8.
25. Paolino D, Ventura CA, Nistico S, Puglisi G, Fresta M. Lecithin microemulsions for the topical administration of ketoprofen: percutaneous adsorption through human skin and in vivo human skin tolerability. Int J Pharm 2002; 244(1-2): 21-31.
26. Sintov AC, Shapiro L. New microemulsion vehicle facilitates percutaneous penetration in vitro and cutaneous drug bioavailability in vivo. J Control Release 2004; 95(2): 173-83.
27. Trotta M, Ugazio E, Peira E, Pulitano C. Influence of ion pairing on topical delivery of retinoic acid from microemulsions. J Control Release 2003; 86(2-3): 315-21.
28. Peltola S, Saarinen-Savolainen P, Kiesvaara J, Suhonen TM, Urtti A. Microemulsions for topical delivery of estradiol. Int J Pharm 2003; 254(2): 99-107.
29. Alvarez-Figueroa MJ, Blanco-Mendez J. Transdermal delivery of methotrexate: iontophoretic delivery from hydrogels and passive delivery from microemulsions. Int J Pharm 2001; 215(1-2): 57-65.
30. Baroli B, Lopez-Quintela MA, Delgado-Charro MB, Fadda AM, Blanco-Mendez J. Microemulsions for topical delivery of 8-methoxsalen. J Control Release 2000; 69(1): 209-18.
31. Fang J-Y, Hong C-T, Chiu W-T, Wang Y-Y. Effect of liposomes and niosomes on skin permeation of enoxacin. Int J Pharm 2001; 219(1-2): 61-72.
32. Garg G, Saraf S. Cubosomes: an overview. Biol Pharm Bull 2007; 30(2): 350-3.
33. Mura S, Pirot F, Manconi M, Falson F, Fadda AM. Liposomes and niosomes as potential carriers for dermal delivery of minoxidil. J Drug Target 2007; 15(2): 101-8.
34. Fang J-Y, Yu S-Y, Wu P-C, Huang Y-B, Tsai Y-H. In vitro skin permeation of estradiol from various proniosome formulations. Int J Pharm 2001; 215(1-2): 91-9.
35. Ting WW, Vest CD, Sontheimer RD. Review of traditional and novel modalities that enhance the permeability of local therapeutics across the stratum corneum. Int J Dermatol 2004; 43(7): 538-47.
36. Choi MJ, Maibach HI. Liposomes and niosomes as topical drug delivery systems. Skin Pharmacol Physiol 2005; 18(5): 209-19.
37. Schreier H, Bouwstra J. Liposomes and niosomes as topical drug carriers: Dermal and transdermal drug delivery. J Control Release 1994; 30(1): 1-15.
38. Manconi M, Sinico C, Valenti D, Lai F, Fadda AM. Niosomes as carriers for tretinoin. III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin. Int J Pharm 2006; 311(1-2): 11-9.
39. Shahiwala A, Misra A. Studies in topical application of niosomally entrapped Nimesulide. J Pharm Pharm Sci 2002; 5(3): 220-5.
40. Nasr M, Mansour S, Mortada ND, Elshamy AA. Vesicular aceclofenac systems: A comparative study between liposomes and niosomes. J Microencapsul 2008: 1-14.
41. Manosroi A, Jantrawut P, Manosroi J. Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with diclofenac diethylammonium. Int J Pharm 2008; 360(1-2): 156-63.
42. Balasubramaniam A, Kumar VA, Pillai KS. Formulation and in vivo evaluation of niosome-encapsulated daunorubicin hydrochloride. Drug Dev Ind Pharm 2002; 28(10): 1181-93.
43. Arunothayanun P, Turton JA, Uchegbu IF, Florence AT. Preparation and in vitro/in vivo evaluation of luteinizing hormone releasing hormone (LHRH)-loaded polyhedral and spherical/tubular niosomes. J Pharm Sci 1999; 88(1): 34-8.
44. Esposito E, Cortesi R, Drechsler M, et al. Cubosome dispersions as delivery systems for percutaneous administration of indomethacin. Pharm Res 2005; 22(12): 2163-73.
45. Spicer PT. Progress in liquid crystalline dispersions: Cubosomes. Curr Opin Colloid Interface Sci 2005; 10(5-6): 274-9.
46. Norlen L, Al-Amoudi A. Stratum corneum keratin structure, function, and formation: the cubic rod-packing and membrane templating model. J Invest Dermatol 2004; 123: 715-32.
47. Kreuter J. Possibilities of using nanoparticles as carriers for drugs and vaccines. J Microencapsul 1988; 5(2): 115-27.
48. Lademann J, Richter H, Teichmann A, et al. Nanoparticles--an efficient carrier for drug delivery into the hair follicles. Eur J Pharm Biopharm 2007; 66(2): 159-64.
49. Lboutounne H, Faivre V, Falson F, Pirot F. Characterization of transport of chlorhexidine-loaded nanocapsules through hairless and Wistar rat skin. Skin Pharmacol Appl Skin Physiol 2004; 17(4): 176-82.
50. Meidan VM, Bonner MC, Michniak BB. Transfollicular drug delivery-Is it a reality? Int J Pharm 2005; 306(1-2): 1-14.
51. Vogt A, Mandt N, Lademann J, Schaefer H, Blume-Peytavi U. Follicular targeting-a promising tool in selective dermatotherapy. J Investig Dermatol Symposium Proceedings/The Society For Investigative Dermatology, Inc. [And] European Society For Dermatological Research 2005; 10(3): 252-5.
52. Rolland A. In: Rolland A, Ed. Particulate carriers in dermal and transdermal delivery: myth or reality? New York, Marcel Dekker 1993; pp. 367-421.
53. Luengo J, Weiss B, Schneider M, et al. Influence of nanoencapsulation on human skin transport of flufenamic acid. Skin Pharmacol Physiol 2006; 19(4): 190-7.
54. Vogt A, Combadiere B, Hadam S, et al. 40 nm, but not 750 or 1,500 nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin. J Invest Dermatol 2006; 126(6): 1316-22.
55. Gomes AJ, Faustino AS, Lunardi CN, Lunardi LO, Machado AEH. Evaluation of nanoparticles loaded with benzopsoralen in rat peritoneal exudate cells. Int J Pharm 2007; 332(1-2): 153-60.
56. Simeonova M, Velichkova R, Ivanova G, Enchev V, Abrahams I. Poly(butylcyanoacrylate) nanoparticles for topical delivery of 5-fluorouracil. Int J Pharm 2003; 263(1-2): 133-40.
57. Yamaguchi Y, Nagasawa T, Nakamura N, et al. Successful treatment of photo-damaged skin of nano-scale atRA particles using a novel transdermal delivery. J Control Release 2005; 104(1): 29-40.
58. Lboutounne H, Chaulet JF, Ploton C, Falson F, Pirot F. Sustained ex vivo skin antiseptic activity of chlorhexidine in poly(epsilon-caprolactone) nanocapsule encapsulated form and as a digluconate. J Control Release 2002; 82(2-3): 319-34.
59. Pirot F, Haftek M, Falson F. A new process for sustained effect of drugs: nanocapsules production with no solvent. France patent FR0852648, 2008.
60. De Jaeghere F, Doelker E, Gurny R. In: Mathiowitz E, Ed. Nanoparticles. New York, John Wiley & Sons 1999; pp. 641-664.
61. Moulari B, Lboutounne H, Pellequer Y, et al. Vectorization of Harungana madagascariensis Lam. ex Poir. (Hypericaceae) ethanolic leaf extract by using PLG-nanoparticles: Antibacterial activity assessment. Drug Dev Res 2005; 65(1): 26-33.
62. Lboutounne H, Guillaume YC, Michel L, et al. Study and development of encapsulated forms of 4, 5', 8-trimethylpsoralen for topical drug delivery. Drug Dev Res 2004; 61(2): 86-94.
63. Dang NTT, Freydiere A-M, Constant H, Falson F, Pirot F. Sustained antibacterial effect of a hand rub gel incorporating chlorhexdine-loaded nanocapsules (Nanochlorex(R)). Int J Pharm 2007; 334(1-2): 166-72.
64. Trullas C, Vila A, Suarez S, Escamilla I. Chitosan coated nanocapsules, a promising new topical delivery system for the improvement of cyclosporin a skin penetration. J Am Acad Dermatol 2007; 56(Suppl 2): AB86.